From: A case report of successfully treated nephrotic syndrome after renal angioplasty
Kanagasundaram et al. [11] | Almirall et al. [12] | This patient | |
---|---|---|---|
Age (years) | 65 | 72 | 48 |
Sex | Female | Male | Male |
Blood pressure (mmHg) | 220/120 | 240/120 | 160/90 |
Anti-HTN drugs | Amlodipine, doxazocin, furosemide | Amlodipine, lisinopril, hydrochlorothiazide | Carvedilol, hydrochlorothiazide |
Serum creatinine (mg/dl) | 2.07 | 1.90 | 1.42 |
Proteinuria before angioplasty | Normal | 100 mg/day | 0.4 g/g |
Renal angiography | |||
Degree of RAS (%) | 95 | 80 | 80 |
Opposite kidney | Non-perfused | Complete occlusion | Non-functional |
Onset of nephrotic syndrome after angioplasty (weeks) | 2 | 3 | 4 |
Proteinuria after angioplasty | 5.9 g/day | 13 g/day | 11.6 g/g |
PRA before angioplasty | – | – | 19.32 ng/ml/hr |
PRA after angioplasty (reference) | 11.6 pmol/ml/hr. (2.8–4.5) | 669 pg/ml (< 300) | 60.6 mg/ml/hr. (1.31–3.95) |
Management | ACEI | ARB | |
Change in proteinuria | 3.1 g/day (2 weeks with ACEI) | 16 g/day | 2.2 g/g (9 weeks with ARB) |
Follow-up | Proteinuria 6.5 g/day (after ACEI withdrawal) | Death due to ICH at 4 months after angioplasty | uPCR 0.4 g/g (1 year with ARB) |